Free Trial Information
BioCentury | Apr 15, 2013
Company News

Microscience management update

Microscience Ltd., London, U.K. Business: Infectious diseases/AIDS Hired: Robert Feldman, Ph.D., as CSO; formerly senior lecturer, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
Read More
BioCentury | Apr 15, 2013
Company News

Microscience scientific advisory board update

Microscience Ltd. , London, U.K. Business: Infectious diseases/AIDS Appointed: David Holden, Ph.D., professor of molecular microbiology, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
Read More
BioCentury | Jul 16, 2012
Company News

Emergent BioSolutions, Prokarium deal

...the oral delivery strain of S. typhi used in Typhella, through its 2005 acquisition of Microscience Ltd....
Read More
BioCentury | Aug 23, 2010
Strategy

The future emerges

...Clinical setbacks and other obstacles have stymied Emergent's previous attempts to branch out. Emergent acquired Microscience Ltd....
Read More
BioCentury | May 31, 2010
Finance

Performance Counts

...Ltd. Vernalis plc (LSE:VER) $18.2 $27.7 Biology: ion channel targets in the peripheral nervous system Microscience Ltd....
Read More
BioCentury | Aug 21, 2006
Finance

Ebb & Flow

...ABI-0043, is being developed to treat Gram-positive pathogens. Bigger by microdosing Similarly, Emergent's acquisition of Microscience...
...the joint lead manager; and HSBC Securities (USA), which will be the co-manager. By acquiring Microscience...
Read More
BioCentury | May 22, 2006
Company News

Vectura, Unilever Ventures Ltd. drug delivery news

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience Ltd....
Read More
BioCentury | May 16, 2006
Company News

Vectura spins out PharmaKodex

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience...
Read More
BioCentury | Dec 19, 2005
Strategy

Heading Stateside

...retained two-thirds of the firm's Cambridge, U.K., R&D facility Microscience Gaithersburg, Md. Emergent BioSolutions acquired Microscience...
Read More
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...including cancer and autoimmune diseases, using XenoMouse and CRGN's genomics-based antigensU. 5/7/03 - Partners with Microscience...
Read More
Items per page:
1 - 10 of 74
BioCentury | Apr 15, 2013
Company News

Microscience management update

Microscience Ltd., London, U.K. Business: Infectious diseases/AIDS Hired: Robert Feldman, Ph.D., as CSO; formerly senior lecturer, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
Read More
BioCentury | Apr 15, 2013
Company News

Microscience scientific advisory board update

Microscience Ltd. , London, U.K. Business: Infectious diseases/AIDS Appointed: David Holden, Ph.D., professor of molecular microbiology, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
Read More
BioCentury | Jul 16, 2012
Company News

Emergent BioSolutions, Prokarium deal

...the oral delivery strain of S. typhi used in Typhella, through its 2005 acquisition of Microscience Ltd....
Read More
BioCentury | Aug 23, 2010
Strategy

The future emerges

...Clinical setbacks and other obstacles have stymied Emergent's previous attempts to branch out. Emergent acquired Microscience Ltd....
Read More
BioCentury | May 31, 2010
Finance

Performance Counts

...Ltd. Vernalis plc (LSE:VER) $18.2 $27.7 Biology: ion channel targets in the peripheral nervous system Microscience Ltd....
Read More
BioCentury | Aug 21, 2006
Finance

Ebb & Flow

...ABI-0043, is being developed to treat Gram-positive pathogens. Bigger by microdosing Similarly, Emergent's acquisition of Microscience...
...the joint lead manager; and HSBC Securities (USA), which will be the co-manager. By acquiring Microscience...
Read More
BioCentury | May 22, 2006
Company News

Vectura, Unilever Ventures Ltd. drug delivery news

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience Ltd....
Read More
BioCentury | May 16, 2006
Company News

Vectura spins out PharmaKodex

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience...
Read More
BioCentury | Dec 19, 2005
Strategy

Heading Stateside

...retained two-thirds of the firm's Cambridge, U.K., R&D facility Microscience Gaithersburg, Md. Emergent BioSolutions acquired Microscience...
Read More
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...including cancer and autoimmune diseases, using XenoMouse and CRGN's genomics-based antigensU. 5/7/03 - Partners with Microscience...
Read More
Items per page:
1 - 10 of 74